He Xiaoting, Wang Huiyu, Wang Runjie, Li Yuting, Li Suqing, Cao Xiufeng, Xu Junying
Oncology Department, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, China.
General Surgery Department, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210012, China.
Heliyon. 2023 Oct 14;9(10):e21056. doi: 10.1016/j.heliyon.2023.e21056. eCollection 2023 Oct.
Esophageal cancer is one of the most unknown and deadliest cancers in the world. Although recent studies have identified some mutations linked to the development of squamous cell carcinoma of the esophagus (ESCC), the specific role of HomeoboxC10 (HOXC10) in the pathogenesis still requires further investigation.
Agilent mRNA single-channel gene expression was employed to identify genome-wide gene signatures in ESCC. These signatures were also verified using qRT-PCR, immunohistochemical staining as well as Western blot. The biological functions of HOXC10 were further investigated through cellular studies conducted on ESCC cells. Survival analysis was conducted utilizing the Kaplan-Meier method. The GEPIA database and the STRING website were utilized to predict the potential targets that bind to HOXC10. Co-immunoprecipitation assays were performed to investigate the binding interaction between HOXC10 and Forkhead Box A3 (FOXA3). Animal models were established to analyze the effects of HOXC10 silencing on tumorigenesis .
The expression levels of HOXC10 mRNA were found to be upregulated in ESCC. Survival analysis revealed a significant association between abnormally elevated levels of HOXC10 mRNA and an unfavorable prognosis in patients with ESCC. studies revealed that the knockdown of HOXC10 expression resulted in the inhibition of the proliferation, invasion, and migrating ability of ESCC cells through the upregulation of FOXA3. Furthermore, tumor-bearing mouse models studies demonstrated that HOXC10 through knockdown techniques significantly suppressed ESCC tumor growth. HOXC10 was found to enhance the activation of the MAPK signaling pathway by regulating FOXA3 in ESCC cells.
These results support a key role for HOXC10 in the tumorigenesis of ESCC by upregulating FOXA3 via the MAPK pathway and highlight its potential as a promising diagnostic and prognostic marker for ESCC.
食管癌是世界上最隐匿且最致命的癌症之一。尽管最近的研究已经确定了一些与食管鳞状细胞癌(ESCC)发生相关的突变,但同源盒C10(HOXC10)在发病机制中的具体作用仍需进一步研究。
采用安捷伦mRNA单通道基因表达技术来识别ESCC中的全基因组基因特征。这些特征还通过qRT-PCR、免疫组织化学染色以及蛋白质印迹法进行了验证。通过对ESCC细胞进行细胞研究,进一步探究了HOXC10的生物学功能。利用Kaplan-Meier方法进行生存分析。使用GEPIA数据库和STRING网站来预测与HOXC10结合的潜在靶点。进行了免疫共沉淀实验以研究HOXC10与叉头框A3(FOXA3)之间的结合相互作用。建立动物模型以分析HOXC10沉默对肿瘤发生的影响。
发现HOXC10 mRNA的表达水平在ESCC中上调。生存分析显示,HOXC10 mRNA水平异常升高与ESCC患者的不良预后之间存在显著关联。研究表明,HOXC10表达的敲低通过上调FOXA3导致ESCC细胞的增殖、侵袭和迁移能力受到抑制。此外,荷瘤小鼠模型研究表明,通过敲低技术,HOXC10显著抑制了ESCC肿瘤的生长。发现在ESCC细胞中,HOXC10通过调节FOXA3增强了MAPK信号通路的激活。
这些结果支持HOXC10通过MAPK途径上调FOXA3在ESCC肿瘤发生中起关键作用,并突出了其作为ESCC有前景的诊断和预后标志物的潜力。